Use of composite endpoints in clinical trials
Stat Med
.
2016 Jan 30;35(2):319-20.
doi: 10.1002/sim.6581.
Authors
Abdul J Sankoh
1
,
Haihong Li
2
,
Ralph B D'Agostino Sr
3
Affiliations
1
Synageva BioPharma, 33 Hayden Avenue, Lexington, MA, 02421, USA.
2
Merrimack Pharmaceuticals, One Kendall Square, Cambridge, MA, 02139, USA.
3
Boston University, 111 Cummington Street, Boston, MA, 02215, USA.
PMID:
26767752
DOI:
10.1002/sim.6581
No abstract available
Publication types
Letter
Comment
MeSH terms
Clinical Trials as Topic / methods*
Drug Evaluation / methods*
Endpoint Determination / methods*
Humans